Bioinvent International Ab Stock Current Valuation
| BINV Stock | SEK 44.60 1.10 2.41% |
Valuation analysis of BioInvent International helps investors to measure BioInvent International's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that BioInvent International's price fluctuation is not too volatile at this time. Calculation of the real value of BioInvent International is based on 3 months time horizon. Increasing BioInvent International's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
BioInvent International's intrinsic value may or may not be the same as its current market price of 44.60, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 44.6 | Real 37.64 | Hype 44.6 |
The intrinsic value of BioInvent International's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence BioInvent International's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of BioInvent International AB helps investors to forecast how BioInvent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioInvent International more accurately as focusing exclusively on BioInvent International's fundamentals will not take into account other important factors: BioInvent International AB Company Current Valuation Analysis
BioInvent International's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current BioInvent International Current Valuation | 1.16 B |
Most of BioInvent International's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioInvent International AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, BioInvent International AB has a Current Valuation of 1.16 B. This is 91.93% lower than that of the Biotechnology sector and 75.06% lower than that of the Health Care industry. The current valuation for all Sweden stocks is 93.03% higher than that of the company.
BioInvent Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioInvent International's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioInvent International could also be used in its relative valuation, which is a method of valuing BioInvent International by comparing valuation metrics of similar companies.BioInvent International is currently under evaluation in current valuation category among its peers.
BioInvent Fundamentals
| Return On Equity | -0.0274 | |||
| Return On Asset | -0.0192 | |||
| Profit Margin | (0.14) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 1.16 B | |||
| Shares Outstanding | 65.8 M | |||
| Shares Owned By Insiders | 11.10 % | |||
| Shares Owned By Institutions | 57.02 % | |||
| Price To Earning | (9.49) X | |||
| Price To Book | 1.40 X | |||
| Price To Sales | 7.25 X | |||
| Revenue | 19.38 M | |||
| Gross Profit | 19.38 M | |||
| EBITDA | (263.32 M) | |||
| Net Income | (278.44 M) | |||
| Cash And Equivalents | 28.46 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 21.53 M | |||
| Debt To Equity | 22.00 % | |||
| Current Ratio | 2.73 X | |||
| Book Value Per Share | 25.92 X | |||
| Cash Flow From Operations | (245.84 M) | |||
| Earnings Per Share | (4.55) X | |||
| Target Price | 81.0 | |||
| Number Of Employees | 93 | |||
| Beta | 0.3 | |||
| Market Capitalization | 1.99 B | |||
| Total Asset | 1.45 B | |||
| Working Capital | 28 M | |||
| Current Asset | 56 M | |||
| Current Liabilities | 28 M | |||
| Z Score | 55.2 | |||
| Net Asset | 1.45 B |
About BioInvent International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioInvent International AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioInvent International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioInvent International AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioInvent Stock Analysis
When running BioInvent International's price analysis, check to measure BioInvent International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioInvent International is operating at the current time. Most of BioInvent International's value examination focuses on studying past and present price action to predict the probability of BioInvent International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioInvent International's price. Additionally, you may evaluate how the addition of BioInvent International to your portfolios can decrease your overall portfolio volatility.